FEATURE ARTICLES
A shrinking FDA and rising supply pressures demand stronger risk management and smarter internal audits. Here’s how pharma can truly “see things as they really are.”
- Innovation, Growth (and Happiness) Projected for Pharma
- Global Implications Of Zero Tariffs On Indian Pharma Exports To China
- Shaping The Future Of GLP-1 Quality
- M&A In GLP-1 Technology: Practical Recommendations And Best Practices
- Makary Talks Faster Drug Reviews, 'Continuous Trials,' DTC Ads
- Process Validation: Working Toward Harmonization Of Terms Used To Identify Validation Lots
- ISPE Awards 8 Innovative Pharma Facilities
PHARMA ONLINE WHITE PAPERS
-
![GettyImages-1807380795-analytics-cell-analysis-laboratory]( "Isolate Bright GFP-Expressing HEK293 Cells For Cell Line Development Workflow")
Isolate Bright GFP-Expressing HEK293 Cells For Cell Line Development WorkflowExplore a high-efficiency workflow for isolating and expanding GFP-expressing HEK293 cells that enables stable, bright clones ideal for imaging and tracking to simplify clonal development.
-
Biomanufacturing Readiness: A Validation Model For Multiproduct Facilities6/12/2025
Optimize your validation strategy to meet evolving regulatory demands and product complexities with a scalable, efficient framework that accelerates facility readiness and ensures consistent quality.
-
Small Molecule API Production: Unveiling The Impact Of Fermentation5/16/2024
Technological developments have led to growth in the suitability of fermentation for a myriad of applications. Explore the impact of the evolution of synthetic biology and supporting technologies on modern fermentation practice.
-
Simplify CAPA In 7 Steps9/20/2024
Discover how to streamline corrective action/preventive action (CAPA) management in regulatory environments in 7 steps.
-
Next Generation Sequencing In Viral Safety Testing7/25/2025
Next Generation Sequencing (NGS) offers a sensitive, high-throughput solution for detecting adventitious viral agents (AVAs), improving biopharmaceutical safety and accelerating regulatory-compliant product development.
-
Extended Head Flats Increase Dwell Time4/25/2024
Explore the extended head flat and how this punch modification can improve the compression of difficult formulations.
PHARMA ONLINE APP NOTES & CASE STUDIES
NEWSLETTER ARCHIVE
- 11.18.25 -- Scaling Smarter In Biologics Manufacturing
- 11.18.25 -- Extreme Weather Is Testing Pharma's Resilience — Is It Ready?
- 11.17.25 -- From Breakdown To Breakthrough: Asset Performance Management
- 11.17.25 -- Streamlining Topical Drug Development With Automation
- 11.16.25 -- Eco-Friendly HBL: Cheaper, Cleaner, And Ready For Pharma
INDUSTRY NEWS
-
![business peope negotiating-GettyImages-637902194]( "9 Drugs Granted Fast Track By FDA's Voucher Program")
9 Drugs Granted Fast Track By FDA's Voucher ProgramWith targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.
-
![Pharmaceutical sorting machine, pills-GettyImages-1499814881]( "Leaders In The Excipient Market: Region And Type")
Leaders In The Excipient Market: Region And TypeThough North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.
-
![GettyImages-2189405678-GLP-1-obesity]( "Pfizer Strengthens Obesity Foothold With Metsera Acquisition")
Pfizer Strengthens Obesity Foothold With Metsera AcquisitionAfter discouraging efforts to bring two oral obesity drugs to market—danuglipron and lotiglipron—this acquisition launches Pfizer back into the obesity therapeutic game.
-
![weight loss, diabetes, insulin pen-GettyImages-2196049931]( "FDA Cracks Down On GLP-1 Imports")
FDA Cracks Down On GLP-1 ImportsGLP-1 bulk drug substances must be detained without physical examination (DWPE) unless they are on a list (Green List) of approved foreign GLP-1 manufacturers.
-
![Dollar Icon from Medical pills-GettyImages-1708867150]( "Oregon Court Upholds Drug Price Transparency Law")
Oregon Court Upholds Drug Price Transparency LawThe law was first enacted in 2018, followed by a lawsuit by Pharmaceutical Research and Manufacturers of America (PhRMA) in 2019, claiming an infringement of free speech for pharmaceutical companies and violation of public property. PhRMA asked the court to bar Oregon from enforcing the law.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Novartis Expands U.S. footprint With New Radioligand Therapy Facility In California11/12/2025
Novartis, a leading global innovative medicines company, today announced the opening of a new 10,000-square-foot radioligand therapy (RLT) manufacturing facility in Carlsbad, California. This state-of-the-art site represents a key milestone in the company’s previously announced $23 billion investment in US infrastructure over the next five years.
-
AES Cleanroom Technology Establishes New Office In Research Triangle Park To Support Regional Drug Manufacturing Growth11/11/2025
AES Cleanroom Technology, an award-winning leader in modular cleanroom design and construction, has opened a new regional office in Research Triangle Park (RTP), reinforcing its commitment to serving the Southeast’s fast-growing life sciences, biotechnology, and advanced manufacturing sectors.
-
Federal Equipment Announces Diagnostics Laboratory Equipment Auction11/10/2025
Federal Equipment held in conjunction with Proxio Group announces diagnostics laboratory equipment auction.
-
Abzena And Mabqi Announce Strategic Partnership To Offer Integrated Discovery Through Development Solution11/6/2025
This collaboration will integrate Mabqi’s antibody discovery capabilities with Abzena’s development and manufacturing services, offering biopharma customers a more streamlined, end-to-end drug development solution.
